Mr. Paul Duffy reports

AI/ML INNOVATIONS LAUNCHES QUANTUM SOMA INITIATIVE WITH DYNEX QUANTUM TECHNOLOGIES FOR CONTACTLESS QUANTUM BIOSENSING PLATFORM

AI-ML Innovations Inc. has launched Quantum Soma, a new artificial intelligence and machine learning project focused on developing a contactless quantum biosensing platform that combines Dynex Quantum Technologies AG's proprietary NV-diamond quantum sensing technology with AI-ML's MaxYield signal intelligence platform.

Effective Sept. 21, 2026, AI-ML entered into a non-binding purchase order with Dynex for up to 2,000 units of Dynex's single-zone NV-Diamond quantum sensor, at a fixed price of 2,500 Swiss francs per unit (approximately $4,242 per unit), representing a maximum aggregate value of five million Swiss francs (approximately $8,484,500) if AI-ML orders the full 2,000 units. AI-ML is not obligated to purchase any units under the purchase order. The purchase order is structured as a drawdown arrangement, allowing AI-ML to place unit orders from time to time at its discretion, with payment due upon delivery and acceptance. AI-ML is not required to make any minimum payments, deposits or development fees to Dynex in connection with the prototype phase, and the arrangement does not include cancellation or termination fees payable by either party.

Dynex and AI-ML intend to work alongside one another toward a combined MaxYield-sensor prototype, with Dynex responsible for integrating its NV-diamond quantum sensor and AI-ML adapting its MaxYield platform to process the sensor's magnetic field output. Dynex is expected to deliver the prototype within approximately nine months. There are no formal, predefined acceptance or validation criteria. AI-ML retains sole discretion to determine whether the prototype performs as intended and is under no obligation to place any order.

Dynex retains all rights to its pre-existing NV-Diamond sensor technology. AI-ML retains ownership of the intellectual property of its MaxYield signal intelligence platform regardless of whether the prototype is completed.

Building Quantum Soma

Quantum Soma is being developed as a contactless biosensing platform designed to read the body's magnetic signatures at a distance. The platform is intended to combine Dynex's NV-diamond quantum sensor technology with a modified version of MaxYield, AI-ML's proprietary signal processing engine, to help separate meaningful physiological signals from environmental and biological noise.

The initial development focus will be the magnetic signature of the human heart, with a broader long-term road map that may include heart, brain, breath and motion signals. AI-ML believes the combination of highly sensitive quantum sensing hardware and advanced AI-based signal processing creates a compelling foundation for a potential new class of contactless physiological measurement tools.

Quantum sensors are an emerging technology class designed to detect extremely small changes in physical environments. NV-diamond sensors use nitrogen-vacancy centres in diamond that respond to magnetic fields, enabling room temperature sensing without the need for cryogenic cooling. Dynex's sensor technology is designed for high-precision magnetic field, temperature and material characterization workflows, and AI-ML has entered into this arrangement with Dynex to evaluate its application in contactless biosignal detection.

Paul Duffy, executive chairman and chief executive officer of AI-ML, commented: "Quantum Soma represents a bold new direction for AI-ML. Our core belief is that the next generation of biosensing will not only be wearable. It will also become increasingly contactless, ambient and intelligent. By combining Dynex's NV-diamond quantum sensing hardware with MaxYield's ability to identify meaningful signals through noise, we believe the pending prototype has the potential to capture an entirely new category of physiological measurement."

Combining quantum sensing with MaxYield

MaxYield was developed by NeuralCloud Solutions Inc., AI-ML's wholly owned subsidiary, as an AI-based signal processing platform for ECG analysis. In Quantum Soma, AI-ML intends to adapt the MaxYield architecture to process magnetic field outputs generated by the Dynex quantum sensor, with the goal of identifying, cleaning and deconvoluting physiological signals beginning with cardiac activity.

Highly sensitive sensors can detect weak signals, but sensitivity alone does not solve the challenge of interpretation. The body produces multiple overlapping physiological signals, and the surrounding environment introduces additional magnetic and electromagnetic noise. AI-ML believes MaxYield's ability to isolate structure from noisy physiological data may provide a critical intelligence layer for turning quantum sensor output into usable biosignal information.

Esmat Naikyar, president of NeuralCloud Solutions and chief product officer of AI-ML, said: "The challenge with extremely sensitive sensing platforms is not only detecting signals, [but] it is [also] determining which part of that signal matters. MaxYield was built to find structures that may be clinically relevant inside noisy physiological data. Quantum Soma gives us an opportunity to apply that intelligence layer to a new sensing modality, beginning with potentially contactless cardiac signal analysis."

A new division for contactless biosignal intelligence

AI-ML intends to operate Quantum Soma as a dedicated project and development initiative, initially focused on the development of a prototype for contactless quantum biosensing for health and wellness applications. The company's initial objective is to validate whether Dynex's quantum sensor hardware, combined with AI-ML's signal intelligence capabilities, can detect and process cardiac magnetic signatures with sufficient fidelity to support future product development.

The company believes that contactless sensing could, over time, create new opportunities across remote monitoring, wellness, clinical research, sleep, mobility and ambient health environments. Any future clinical or diagnostic application of Quantum Soma would be subject to applicable regulatory requirements, validation and clearance or approval in the relevant jurisdictions.

About AI-ML Innovations Inc.

AI-ML is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Its proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights -- supporting earlier diagnosis, personalized treatment and more effective care.

AI-ML's common shares trade on the Canadian Securities Exchange, the OTCQB Venture Market and the Frankfurt Stock Exchange.

We seek Safe Harbor.